Orchid Pharma Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2013
2015
2016
2017
2018
Sales/Revenue
12,603
11,326
8,595
7,770
6,830
Cost of Goods Sold (COGS) incl. D&A
11,699
10,142
7,507
7,186
5,697
Gross Income
904
1,184
1,088
583
1,133
SG&A Expense
2,116
1,310
959
1,091
2,309
EBIT
1,252
185
116
539
1,176
Unusual Expense
574
1,134
525
1,727
-
Non Operating Income/Expense
1,627
419
388
192
203
Interest Expense
3,485
3,581
2,942
3,311
3,016
Pretax Income
3,683
2,213
2,964
5,385
3,990
Income Tax
83
1,276
173
480
462
Equity in Affiliates
-
1
-
-
-
Consolidated Net Income
3,600
938
2,791
4,905
3,528
Net Income
3,587
934
2,791
4,905
3,528
Net Income After Extraordinaries
3,587
934
2,791
4,905
3,528
Net Income Available to Common
3,587
934
2,791
4,905
3,528
EPS (Basic)
50.91
12.76
32.07
55.13
39.65
Basic Shares Outstanding
70
73
87
89
-
EPS (Diluted)
50.44
12.76
32.07
55.13
-
Diluted Shares Outstanding
71
73
87
89
-
EBITDA
428
1,979
1,568
871
157
Other Operating Expense
39
60
13
31
-
Minority Interest Expense
13
4
-
-
-

About Orchid Pharma

View Profile
Address
Orchid Towers
Chennai Tamil Nadu 600034
India
Employees -
Website http://www.orchidpharma.com
Updated 09/14/2018
Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectibles, veterinary products, and non-antibiotics. The company was founded by by Kailasam Raghavendra Rao on July 1, 1992 and is headquartered in Chennai, India.